DOI QR코드

DOI QR Code

Effect of Curcuma longa L. on the Obesity and Insulin Resistance in Sprague-Dawley Rats and db/db Mice

SD계 랫트와 db/db 마우스에서 Curcuma longa L.가 비만과 인슐린저항성에 미치는 영향

  • You, Mi-Kyoung (Department of Food & Nutrition, Mokpo National University) ;
  • Kim, Min-Sook (Department of Food & Nutrition, Mokpo National University) ;
  • Rhyu, Dong-Young (Deparrtment of Oriental Medicine Resources, Mokpo National University) ;
  • Kim, Hyeon-A (Department of Food & Nutrition, Mokpo National University)
  • Received : 2012.10.25
  • Accepted : 2013.01.04
  • Published : 2013.02.28

Abstract

In this study, the effect of Curcuma longa L. on obesity and insulin resistance was investigated in animals fed a moderate high fat diet. The animals used in this study were normal weight Spargue-Dawley (SD) rats and type 2 diabetic obese db/db mice. Accumulation of abdominal adipose tissue and weight gain were inhibited in the animals fed the C. longa extract. C. longa decreased fasting insulin and HOMA-IR in the SD rats, and effectively decreased blood glucose and hemoglobin A1c in db/db mice. C. longa decreased serum free fatty acid (FFA) level in the SD rats. FFA in db/db mice fed C. longa tended to decrease. C. longa significantly decreased serum triglyceride level. Our results collectively represent that C. longa prevented fat accumulation and insulin resistance in both normal weight SD rats and type 2 diabetic obese db/db mice fed a moderate high fat diet.

본 실험은 Curcuma longa L.의 비만, 인슐린 저항성 효과에 대해 알아보기 위하여 C. longa 를 50% 에탄올로 추출물을 제조한 다음 실험동물을 통하여 알아보았다. 실험동물로는 정상동물인 SD계 랫트와 2형 당뇨 모델인 db/db 마우스를 사용하였고 식이로는 고지방식이(15%fat diet)를 사용하였고 C. longa는 식이에 넣어 제공하였다. SD rat 에서 체중, 총지방량은 1.5% 울금식이군이 대조군보다 유의적으로 감소하였다. 혈청에서 인슐린, HOMA-IR, TG는 1.5% 울금식이군이 대조군보다 유의적으로 감소하는 것을 관찰할 수 있었다. db/db 마우스에서 체중은 1.5% 울금식이군이 대조군보다 감소하는 경향을 보였으나 유의적이지는 않았고 총지방량은 1.5% 울금식이군이 대조군보다 유의적으로 감소하는 것을 관찰 할 수 있었다. 본 실험에서 공복 시 혈당은 2주마다 측정하였는데 1.5% 울금식이군이 대조군보다 유의적으로 감소하였고 hemoglobin A1c도 유의적으로 감소하는 것을 관찰 할 수 있었다. 공복 시 혈당과 hemoglobin의 유의적인 감소로 인하여 혈청에서 측정한 insulin, HOMA-IR이 감소하는 경향을 보인 것으로 사료된다. 이상의 결과로 보아 C. longa 추출물은 체중조절 및 혈당조절에 도움이 되는 천연약물로서의 기능성이 입증되었다고 사료된다.

Keywords

References

  1. Gower BA, Munoz J, Desmond R, Hailey RH, Jiao X (2006) Changes in intra-abdominal fat in early postmenopausal women: effects of hormone use. Obesity, 14, 1046-1055 https://doi.org/10.1038/oby.2006.120
  2. Castejon MG, Casado AR (2011) Dietary phytochemicals and their potential effects on obesity: A review. Pharmacol Res, 64, 438-455 https://doi.org/10.1016/j.phrs.2011.07.004
  3. Koh-Banerjee p, Wang Y, Hu FB, Spoegelman D, Willett WC, Rimm EB (2004) Changes in cody weight and body fat distribution as risk factors for clinical diabetes in us men. Am J Epidemiol, 159, 1150-1159 https://doi.org/10.1093/aje/kwh167
  4. Goodpaster BH, Krishmaswami S, Harris TB, Katsiaras A, Kritchevsky SB, Simonsick EM, Mevitt M, Holvoet P, Newman AB (2005) Obesity, regional fat distribution and the metabolic syndrome in older men and women. Arch Int Med, 165, 777-783 https://doi.org/10.1001/archinte.165.7.777
  5. Leahy HK (2005) Pathogenesis of type 2 diabetes Mellitus. Archi Med Res, 36, 197-209 https://doi.org/10.1016/j.arcmed.2005.01.003
  6. Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, Kotan K, Quadro L, Kahn BB (2005) Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature, 436, 356-362 https://doi.org/10.1038/nature03711
  7. Despres, JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ (1996) Hyperinsulinemia as an independant risk factor for ischemic heart disease. N Engl J Med, 334, 952-957 https://doi.org/10.1056/NEJM199604113341504
  8. Okada K, Wangpoentrakul C, Tanaka T, Toyokuni S, Uchida K, Isawa T (2001) Curcumin and especially tetrahydrocurcumin ameliorate oxidative stress-induced renal injury in mice. J Nutr, 131, 2090-2095
  9. Sharma S, Kulkarni SK, Chopra K (2006) Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. Clin Exp Pharmacil Physio, 33, 940-945 https://doi.org/10.1111/j.1440-1681.2006.04468.x
  10. Shishodia S, Singh T, Chatuvedi MM (2007) Modulation of transcription factors by curcumin. Adv Exp Biol, 595, 127-148 https://doi.org/10.1007/978-0-387-46401-5_4
  11. Pari L, Murugan P (2005) Effect of tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes in streptozotocin induced diabetic rats. J Basic Clin Physiol Pharmacol, 16, 257-274
  12. El‐Moselhy M, Taye A, Sharkawi SS, El-Sisi SFI, Ahmed AF (2011) The antihyperglycenic effect of curcumin in high fat diet fed rats. Role of TNF-${\alpha}$ and free fatty acids. Food Chem Toxidol, 49, 1123-1140
  13. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R (1995) Identification and expression cloning of a leptin receptor, OB-R. Cell, 83, 1263-1271 https://doi.org/10.1016/0092-8674(95)90151-5
  14. Coleman DL (1978) Ovese and diabetes: Two mutant genes causing diabetes-obesity syndroms in mice. Diabetologia, 14, 141-148 https://doi.org/10.1007/BF00429772
  15. The Korean Nutrition Society (2010) Dietary reference intakes for Koreans. 1st revision 2010. Seoul: The Korean Nutrition Society.
  16. Matthews DR, Hosker JP, Rudenski A, Naylor BA, Treacher DF, Turner RC (1985) Homeostasis model assessment: insulin resistance and geta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419 https://doi.org/10.1007/BF00280883
  17. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I (2004) Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol, 24, 29-33 https://doi.org/10.1161/01.ATV.0000099786.99623.EF
  18. Expert pannel in detecton evaluation and treatment of high Blood cholesterol in adults. (2001) Executive summary of the third report of the national cholesterol education program(NCEP) expert panel in detection, evaluation, and treatment of high blood cholesterol in adults(Adult treatment panel III). JAMA, 285, 2486-2497 https://doi.org/10.1001/jama.285.19.2486
  19. Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome-a new world-side definition: IDF epidemiology task force consensus group. Lancet, 366, 1059-1062. https://doi.org/10.1016/S0140-6736(05)67402-8
  20. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome, Lancet, 365, 1415-1428 https://doi.org/10.1016/S0140-6736(05)66378-7
  21. Sumner AE, Cowie CC (2008) Ethnic differences in the ability of triglyceride levels to identify insulin resisrance. Atherosclerosis, 196, 696-703 https://doi.org/10.1016/j.atherosclerosis.2006.12.018
  22. Berg AH, Combs TP, Scherer PE (2002) ACRP30/ adiponectin: An adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab, 13, 84-89 https://doi.org/10.1016/S1043-2760(01)00524-0
  23. Tsao TS, Lodish HF, Fruebis J (2002) ACRP 30, a new hormone controlling fat and glucose metabolism. European J Pharm, 440, 213-221 https://doi.org/10.1016/S0014-2999(02)01430-9
  24. Goodpaster BH, Krishnaswami S, Resnick H, Kelley DE, Haggerty C, Harris TB, Schwartx AV, Kritchevsky S, Newman AB (2003) Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women. Diabetes care, 165, 372-379
  25. Bergman RN, Ader M (2000) Free fatty acid and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metabol, 11, 351-356 https://doi.org/10.1016/S1043-2760(00)00323-4
  26. Avramiglu RK, Basciano H, Adeli K (2006) Lipid and lipid protein dysregulation in insulin resistant states. Clin Clim Acta, 368, 1-19 https://doi.org/10.1016/j.cca.2005.12.026

Cited by

  1. Inhibitory effect of dietary turmeric (Curcuma longa L.) ethanol extract on DMBA-induced mammary carcinogenesis in rats vol.21, pp.3, 2014, https://doi.org/10.11002/kjfp.2014.21.3.301
  2. 명월초, 여주 및 울금을 포함하는 돼지감자 복합물의 streptozotocin 유발 당뇨쥐에서 혈당강하 및 체내 지질개선에 미치는 영향 vol.28, pp.6, 2018, https://doi.org/10.5352/jls.2018.28.6.671